FrancophonIA/ELRC3.0 huggingface dataset:
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/042
Croatian: EU/1/97/031/042
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/037
Croatian: EU/1/97/031/037
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/045
Croatian: EU/1/97/031/045
English: QUALITATIVE AND QUANTITATIVE COMPOSITION NeoRecormon 500 IU solution for injection in pre-filled syringe One pre-filled syringe with 0.3 ml solution for injection contains 500 international units (IU) corresponding to 4.15 micrograms epoetin beta* (recombinant human erythropoietin).
Croatian: Jedna napunjena štrcaljka s 0,3 ml otopine za injekciju sadrži 500 internacionalnih jedinica (IU) što odgovara 4,15 mikrograma epoetina beta* (rekombinantnog ljudskog eritropoetina).
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/029
Croatian: EU/1/97/031/029
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/025
Croatian: EU/1/97/031/025
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/026
Croatian: EU/1/97/031/026
English: 1 syringe contains: Urea, sodium chloride, polysorbate 20, sodium dihydrogen phosphate dihydrate, disodium phosphate dodecahydrate, calcium chloride dihydrate, glycine, L-Leucine, L-Isoleucine, L-Threonine, L-glutamic acid, L-Phenylalanine, and water for injections.
Croatian: POPIS POMOĆNIH TVARI 1 štrcaljka sadrži: ureju, natrijev klorid, polisorbat 20, natrijev dihidrogenfosfat, natrijev hidrogenfosfat, kalcijev klorid, glicin, L-leucin, L-izoleucin, L-treonin, L-glutamatnu kiselinu, Lfenilalanin i vodu za injekcije.
English: NeoRecormon 3000 IU solution for injection in pre-filled syringe One pre-filled syringe with 0.3 ml solution for injection contains 3000 international units (IU) corresponding to 24.9 micrograms epoetin beta* (recombinant human erythropoietin).
Croatian: Jedna napunjena štrcaljka s 0,3 ml otopine za injekciju sadrži 3000 internacionalnih jedinica (IU) što odgovara 24,9 mikrograma epoetina beta* (rekombinantnog ljudskog eritropoetina).
English: NeoRecormon 4000 IU solution for injection in pre-filled syringe One pre-filled syringe with 0.3 ml solution for injection contains 4000 international units (IU) corresponding to 33.2 micrograms epoetin beta* (recombinant human erythropoietin).
Croatian: Jedna napunjena štrcaljka s 0,3 ml otopine za injekciju sadrži 4000 internacionalnih jedinica (IU) što odgovara 33,2 mikrograma epoetina beta* (rekombinantnog ljudskog eritropoetina).
English: NeoRecormon 10,000 IU solution for injection in pre-filled syringe One pre-filled syringe with 0.6 ml solution for injection contains 10,000 international units (IU) corresponding to 83 micrograms epoetin beta* (recombinant human erythropoietin).
Croatian: Jedna napunjena štrcaljka s 0,6 ml otopine za injekciju sadrži 10 000 internacionalnih jedinica (IU) što odgovara 83 mikrograma epoetina beta* (rekombinantnog ljudskog eritropoetina).
English: Roche d.o.o Tel: +385 1 4722 333
Croatian: Tel: + 385 1 47 22 333
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/044
Croatian: EU/1/97/031/044
English: Sodium dihydrogen phosphate dihydrate, Disodium phosphate dodecahyrate, Calcium chloride dihydrate, Glycine,
Croatian: natrijev dihidrogenfosfat, natrijev hidrogenfosfat,
English: · Contact your healthcare professional if you have any questions.
Croatian: Ako imate bilo kakvih pitanja, obratite se svom zdravstvenom radniku.
English: For storage conditions of the reconstituted medicinal product see section 6.3.
Croatian: Uvjete čuvanja otopine pripremljene za primjenu vidjeti u dijelu 6.3. 6.5 Vrsta i sadržaj spremnika
English: Sodium chloride, Polysorbate 20, Sodium dihydrogen phosphate, Disodium hydrogen phosphate, Calcium chloride, Glycine,
Croatian: POPIS POMOĆNIH TVARI 1 bočica sadrži: ureju, natrijev klorid, polisorbat 20, natrijev dihidrogenfosfat, natrijev hidrogenfosfat,
English: MARKETING AUTHORISATION NUMBER(S) EU/1/97/031/031
Croatian: EU/1/97/031/031
English: The powder is white.
Croatian: Prašak je bijel.
English: Allow to stand for 5 minutes.
Croatian: Pustite da odstoji 5 minuta.
English: Allow the area to dry.
Croatian: Pustite da se to područje osuši.
English: Let it warm up on its own.
Croatian: Pustite da se sama zagrije.
English: You should then continue with injections at the recommended intervals as before.
Croatian: Nakon toga trebate nastaviti s injekcijama u preporučenim intervalima kao i ranije.
English: Your doctor may check your blood regularly if considered necessary.
Croatian: Liječnik Vam može redovito kontrolirati krv ako to bude smatrao potrebnim.
English: Satisfactory clinical response after 7 days?
Croatian: Zadovoljavajući klinički odgovor nakon 7 dana?
English: If you feel a spinning sensation or feel tired, do not drive or use any tools or machines until you are feeling normal again.
Croatian: Ako osjećate da Vam se vrti ili se osjećate umorno, nemojte voziti ili koristiti bilo kakve alate ili strojeve dok se opet ne budete osjećali normalno.
English: Your doctor may decide to delay or interrupt your treatment, but only if necessary.
Croatian: Liječnik može odlučiti odgoditi ili prekinuti Vaše liječenje, ali samo ako to bude nužno.
English: These can include:
Croatian: One mogu uključivati:
English: - if you have, or suspect you have, an active and severe infection.
Croatian: ako imate, ili sumnjate da imate, aktivnu i tešku infekciju.
English: Please note that the preparation of the injection takes about 30 minutes.
Croatian: Napominjemo da za pripremu injekcije treba oko 30 minuta.
English: Fever lasting longer than 3 days or any other symptoms that might suggest a serious infection.
Croatian: Vrućica koja traje dulje od 3 dana ili bilo koji drugi simptomi koji mogu ukazivati na ozbiljnu infekciju.
English: (There will be water remaining in the vial.)
Croatian: (U bočici će ostati nešto vode.)
English: The majority of these events were mild in severity.
Croatian: Većina tih događaja bila je blaga po težini.
English: Pain in the back or muscles.
Croatian: Bol u leđima ili mišićima.
English: Steady state was reached after 110 days.
Croatian: Stanje dinamičke ravnoteže bilo je dosegnuto nakon 110 dana.
English: Physician Global Assessment < 2
Croatian: Liječnikova opća procjena <2
English: if you need to have any vaccinations.
Croatian: ako trebate ikakva cjepiva.
English: Overall study population; N=454
Croatian: Cjelokupna ispitivana populacija; N=454
English: The total treatment duration ranged from 6 months to 2 years.
Croatian: Ukupno trajanje liječenja bilo je od 6 mjeseci do 2 godine.
English: Then talk to the doctor to discuss when you should inject the next dose.
Croatian: Zatim razgovarajte s liječnikom kada biste trebali ubrizgati sljedeću dozu.
English: This additional dose could be provided as early as 7 days after the first treatment dose.
Croatian: Ta dodatna doza mogla se dati već 7 dana nakon prve doze u liječenju.
English: If possible, avoid touching the rubber stopper with your fingers.
Croatian: Ako je moguće, izbjegavajte dodirivanje gumenog čepa prstima.
English: However, clinical experience in such patients is limited.
Croatian: Međutim, klinička iskustva u takvih bolesnika su ograničena.
English: Neutropenia and leukopenia
Croatian: Neutropenija i leukopenija
English: Your healthcare provider will instruct you on the right amount for you.
Croatian: Osoba koja Vam pruža zdravstvenu skrb uputit će Vas u to koja je odgovarajuća količina za Vas.
English: It is important to tell your doctor if you are pregnant, if you think you may be pregnant or are planning to have a baby.
Croatian: Važno je da obavijestite svog liječnika ako ste trudni, ako mislite da biste mogli biti trudni ili ako planirate imati dijete.
English: Wash your hands with soap and water, then dry them on a clean towel.
Croatian: Operite ruke sapunom i vodom, zatim ih osušite čistim ručnikom.
English: Of the patients who had achieved a complete response, 89.3% maintained response without relapsing.
Croatian: Od bolesnika koji su postigli potpuni odgovor, 89,3% održalo je odgovor bez relapsa.
English: Long term data from observational study
Croatian: Dugoročni podaci iz opservacijskog ispitivanja
English: If you use more Ilaris than you should
Croatian: Ako primijenite više Ilarisa nego što ste trebali
English: Your doctor will discuss with you the need to start or adjust a urate lowering therapy to lower the uric acid level in your blood.
Croatian: Vaš liječnik će razgovarati s Vama o potrebi započinjanja ili prilagođavanja terapije za snižavanje urata kako bi se smanjila razina mokraćne kiseline u Vašoj krvi.
English: Essential preparation
Croatian: Osnovna priprema
English: This may affect your ability to drive or use tools or machines.
Croatian: To može utjecati na Vašu sposobnost upravljanja vozilima ili korištenja alata ili strojeva.
English: Two open-label, uncontrolled, long-term phase III studies were performed.
Croatian: Provedena su dva otvorena, nekontrolirana, dugoročna ispitivanja faze III.
English: These are used mainly in rheumatic and autoimmune diseases.
Croatian: Oni se primjenjuju uglavnom kod reumatskih i autoimunih bolesti.
English: (2°C to 8°C) and used within 24 hours.
Croatian: (2°C do 8°C) i upotrijebiti u roku od 24 sata.
English: The clinical significance of this observation is unknown.
Croatian: Klinički značaj tog opažanja nije poznat.
English: More information on each of these diseases is given below.
Croatian: Više informacija o svakoj od ovih bolesti navedeno je u nastavku.
English: Canakinumab also reduced the risk of subsequent attacks (see Table 5).
Croatian: Kanakinumab je također smanjio rizik od naknadnih napada (vidjeti Tablicu 5).
English: Results for the components of the adapted paediatric ACR which included systemic and arthritic components, were consistent with the overall ACR response results.
Croatian: Rezultati za komponente prilagođenog pedijatrijskog ACR odgovora koje su uključivale sistemske i artritične komponente bili su u skladu s ukupnim rezultatima ACR odgovora.
English: No neutralising antibodies were detected.
Croatian: Nisu bila uočena neutralizirajuća protutijela.
English: Do not stop taking Ilaris unless your doctor tells you to.
Croatian: Nemojte prestati primjenjivati Ilaris osim ako Vam to ne savjetuje Vaš liječnik.
English: Do not try to administer an injection yourself if you have not been properly trained or if you are not sure how to do it.
Croatian: Ne pokušavajte sami primijeniti injekciju ako niste pravilno obučeni ili ako niste sigurni kako to učiniti.
English: The risk for the foetus/mother is unknown.
Croatian: Rizik za fetus/majku nije poznat.
English: Tell your doctor or your child's doctor immediately if you notice any of these symptoms.
Croatian: Odmah se obratite svom liječniku ili liječniku vašeg djeteta ako primijetite bilo koji od tih simptoma.
English: Date of first authorisation: 23 October 2009 Date of latest renewal: 19 June 2014
Croatian: Datum posljednje obnove odobrenja: 19. lipnja 2014.
English: The studies were 12 weeks followed by 12-week double-blind extension.
Croatian: Ispitivanja su trajala 12 tjedana, nakon čega je uslijedio dvostruko slijepi produžetak od 12 tjedana.
English: Women who are pregnant or who desire to become pregnant should therefore only be treated after a thorough benefit-risk evaluation.
Croatian: Žene koje su trudne ili koje žele zatrudnjeti smiju se stoga liječiti samo nakon temeljite procjene koristi i rizika.
English: Always use new, unopened needles and syringes.
Croatian: Uvijek upotrebljavajte nove, neotvorene igle i štrcaljke.
English: Gouty arthritis: Ilaris is not recommended for children or adolescents under 18 years of age.
Croatian: Urični artritis: Ilaris se ne preporučuje za djecu ili adolescente mlađe od 18 godina.
English: Do not inject air into the liquid.
Croatian: Ne ubrizgavajte zrak u tekućinu.
English: If bleeding occurs, apply a clean, dry cotton swab over the area, and press gently for 1 to 2 minutes, or until bleeding stops.
Croatian: Ako dođe do krvarenja, stavite čisti, suhi pamučni jastučić na to područje i lagano pritišćite 1 do 2 minute ili dok se krvarenje ne zaustavi.
English: Frequency categories are defined using the following convention: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from the available data).
Croatian: Kategorije učestalosti definirane su prema sljedećem načelu: vrlo često (≥1/10); često (≥1/100 i <1/10); manje često (≥1/1000 i <1/100); rijetko (≥1/10 000 i <1/1000); vrlo rijetko (<1/10 000); nepoznato (ne može se procijeniti iz dostupnih podataka).
English: This means that it is injected through a short needle into the fatty tissue just under the skin.
Croatian: To znači da se ubrizgava kroz kratku iglu u masno tkivo ispod kože.
English: The mean number of gouty arthritis attacks in the previous 12 months was 6.5.
Croatian: Srednja vrijednost broja napada uričnog artritisa u prethodnih 12 mjeseci bio je 6,5.
English: Do not use Ilaris - if you are allergic to canakinumab or any of the other ingredients of this medicine (listed in section 6).
Croatian: Nemojte primjenjivati Ilaris - ako ste alergični na kanakinumab ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.).
English: If you accidentally inject more Ilaris than the recommended dose, it is unlikely to be serious, but you should inform your doctor, pharmacist or nurse as soon as possible.
Croatian: Ako slučajno ubrizgate više Ilarisa od preporučene doze, mala je vjerojatnost da će to biti ozbiljno, ali trebate čim prije obavijestiti svoga liječnika, ljekarnika ili medicinsku sestru.
English: 9/l were reported in 2% of patients in the comparative trials.
Croatian: 9/l zabilježeno je u 2% bolesnika u komparativnim ispitivanjima.
English: Subcutaneous absorption rate was estimated to decrease with age and appeared to be fastest in the youngest patients.
Croatian: Procijenjeno je da se brzina supkutane apsorpcije smanjuje s dobi, a čini se da je najbrža u najmlađih bolesnika.
English: - If not used immediately after mixing, the solution should be stored in the refrigerator
Croatian: - Ako se ne upotrijebi odmah nakon miješanja, otopinu treba pohraniti u hladnjak
English: Fewer patients aged 2 to < 4 years achieved complete response (57.1%) than older paediatric and adult patients.
Croatian: Manje je bolesnika u dobi od 2 do <4 godine postiglo potpun odgovor (57,1%) u usporedbi sa starijim pedijatrijskim i odraslim bolesnicima.
English: Day 29
Croatian: 29. dan
English: The terminal half-life ranged from 22.9 to 25.7 days, similar to the pharmacokinetic properties observed in adults.
Croatian: Terminalni poluvijek bio je od 22,9 do 25,7 dana, što je slično farmakokinetičkim svojstvima uočenima kod odraslih osoba.
English: Patients who experience such symptoms during Ilaris treatment should wait for this to resolve completely before driving or operating machines.
Croatian: Bolesnici koji osjete takve simptome tijekom liječenja Ilarisom moraju čekati da se oni u potpunosti povuku prije upravljanja vozilima ili rada sa strojevima.
English: Particularly in adult patients, this evaluation should include a detailed medical history.
Croatian: Osobito u odraslih bolesnika, to mora uključivati detaljnu anamnezu.
English: The mean terminal half-life was 26 days.
Croatian: Srednja vrijednost poluvijeka bila je 26 dana.
English: For instructions on how to administer Ilaris injections, please read the section “Instructions for use” at the end of this leaflet.
Croatian: Za upute o primjeni injekcija Ilarisa, pročitajte odjeljak „Upute za uporabu“ na kraju ove upute.
English: In the event of conversion from a negative to a positive PPD test, especially in high-risk patients, alternative means of screening for a tuberculosis infection should be considered.
Croatian: U slučaju prijelaza iz negativnog u pozitivan PPD test, osobito u visokorizičnih bolesnika, potrebno je razmotriti druge načine probira za infekciju tuberkulozom.
English: Other side effects of Ilaris include: Very common (may affect more than 1 in 10 people): Infections of any kind.
Croatian: Ostale nuspojave Ilarisa uključuju: Vrlo često (mogu se javiti u više od 1 na 10 osoba): Infekcije bilo koje vrste.
English: Treatment difference for all ACR scores was significant (p ≤ 0.0001)
Croatian: Razlika između terapija za sve ACR odgovore bila je značajna (p ≤ 0,0001)
English: Table 4 Paediatric ACR response and disease status at days 15 and 29
Croatian: Tablica 4 Pedijatrijski ACR odgovor i status bolesti nakon 15 i 29 dana
English: Allow the vial to warm to room temperature before injection.
Croatian: Pustite da se bočica zagrije do sobne temperature prije injekcije.
English: The needle should not be in the liquid at this point.
Croatian: Igla u ovoj fazi ne smije biti u tekućini.
English: Additionally, 6 paediatric patients under the age of 2 years were evaluated in a small open-label clinical study.
Croatian: Uz to, 6 pedijatrijskih bolesnika mlađih od 2 godine bilo je ocijenjeno u malom otvorenom kliničkom ispitivanju.
English: Bioavailability (AUCss) was not affected.
Croatian: Nije bilo utjecaja na bioraspoloživost (AUCss).
English: Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).
Croatian: Ispitivanja na životinjama ne upućuju na izravne ili neizravne štetne učinke s obzirom na reproduktivnu toksičnost (vidjeti dio 5.3).
English: This is clinically relevant for CYP450 substrates with a narrow therapeutic index where the dose is individually adjusted.
Croatian: To je klinički relevantno za CYP450 supstrate s uskim terapijskim indeksom gdje se doza individualno prilagođava.
English: Canakinumab had no effect on male fertility parameters in marmosets (C. jacchus).
Croatian: Kanakinumab nije imao učinka na parametre muške plodnosti marmozeta (C. jacchus).
English: NOTE: The required amount depends on the dose to be administered.
Croatian: Potrebna količina ovisi o dozi koju treba primijeniti.
English: Do not try to heat the vial.
Croatian: Ne pokušavajte zagrijavati bočicu.
English: There is a limited amount of data from the use of canakinumab in pregnant women.
Croatian: Postoji ograničena količina podataka o primjeni kanakinumaba u trudnica.
English: The primary objective was to assess the proportion of patients who were free of relapse at week 24, including those patients whose dose was increased.
Croatian: Primarni cilj bio je ocijeniti udio bolesnika koji su bili bez relapsa nakon 24 tjedna, što uključuje i one bolesnike kojima je doza povećana.
English: If you have gouty arthritis, your treatment will be overseen by a doctor with specialist training.
Croatian: Ako imate urični artritis, Vaše će liječenje nadzirati liječnik sa specijalističkom izobrazbom.
English: Paediatric patients:
Croatian: Pedijatrijski bolesnici:
English: (There may be solution remaining in the vial.)
Croatian: (Moguće je da je u bočici ostalo nešto otopine.)
English: Swirl the vial slowly at an angle of about 45° for approximately 1 minute and allow to stand for about 5 minutes.
Croatian: Polako vrtite bočicu pod kutem od oko 45° otprilike 1 minutu i pustite da odstoji oko 5 minuta.
English: Clinical experience in CAPS patients without a confirmed mutation in the NLRP3 gene is limited.
Croatian: Kliničko iskustvo kod bolesnika s CAPS-om bez potvrđene mutacije u genu NLRP3 je ograničeno.
English: The median improvement from baseline to end of Part I of study G2301 was 0.88 (79%).
Croatian: Medijan poboljšanja od početne vrijednosti do kraja prvog dijela ispitivanja G2301 bio je 0,88 (79%).
English: No gender or age-related pharmacokinetic differences were observed after correction for body weight.
Croatian: Nisu bile uočene nikakve farmakokinetičke razlike povezane sa spolom ili dobi nakon korekcije za tjelesnu težinu.
English: Ilaris should be injected by a healthcare professional only.
Croatian: Ilaris smije ubrizgavati samo zdravstveni djelatnik.
English: C-reactive protein ≤ 10 mg/l
Croatian: C-reaktivni protein ≤10 mg/l
English: The efficacy observed in the studies G2305 and G2301 was maintained in the ongoing, open-label long-term extension study (data available through median of 49 weeks of follow-up).
Croatian: Djelotvornost uočena u ispitivanjima G2305 i G2301 održala se u tekućem, otvorenom dugoročnom produžetku ispitivanja (podaci dostupni do medijana od 49 tjedana praćenja).
English: These symptoms could be due to a serious infection, an unusual infection (opportunistic infection) or be related to low levels of white blood cells (called leukopenia or neutropenia).
Croatian: Razlog tih simptoma može biti ozbiljna infekcija, neuobičajena infekcija (oportunistička infekcija) ili može biti povezan s niskim razinama bijelih krvnih stanica (što se zove leukopenija ili neutropenija).
English: Canakinumab N=43
Croatian: Kanakinumab N=43
English: Pharmacotherapeutic group: Immunosuppressants, interleukin inhibitors, ATC code: L04AC08
Croatian: Farmakoterapijska skupina: Imunosupresivi, inhibitori interleukina, ATK oznaka: L04AC08
English: Other medicines and Ilaris
Croatian: Drugi lijekovi i Ilaris
English: Interactions between canakinumab and other medicinal products have not been investigated in formal studies.
Croatian: Interakcije između kanakinumaba i drugih lijekova nisu bile ispitivane u formalnim ispitivanjima.
English: Of the total 128 patients who entered Part I taking corticosteroids, 92 attempted corticosteroid tapering.
Croatian: Od ukupno 128 bolesnika koji su ušli u prvi dio uzimajući kortikosteroide, 92 je pokušalo smanjiti dozu kortikosteroida.
English: p=0.2798 Risk reduction of subsequent gouty arthritis attacks as measured by time to first new flare (24 weeks)
Croatian: p=0,2798 Smanjenje rizika od naknadnih napada uričnog artritisa mjereno vremenom do prvog novog razbuktavanja bolesti (24 tjedna)
English: What Ilaris is and what it is used for
Croatian: Što je Ilaris i za što se koristi
English: The risk for the development of malignancies with anti-interleukin (IL)-1 therapy is unknown.
Croatian: Rizik razvoja zloćudnih bolesti uz terapiju protiv interleukina (IL)-1 nije poznat.
English: Patients > 28 days but < 2 years of age were allowed to enter the study directly into an open-arm of Part II as nonrandomised patients (and were excluded from the primary efficacy analysis).
Croatian: Bolesnici u dobi od >28 dana ali <2 godine smjeli su se uključiti u ispitivanje izravno u otvorenu skupinu u II. dijelu kao nerandomizirani bolesnici (i bili su isključeni iz primarne analize djelotvornosti).
English: A live vaccine should normally be given 3 months after your last injection of Ilaris and 3 months before the next one.
Croatian: Živo cjepivo se obično daje nakon što je proteklo 3 mjeseca od Vaše posljednje injekcije Ilarisa i 3 mjeseca prije sljedeće injekcije.
English: The apparent volume of distribution (V/F) was 4.96 l at body weight of 55 kg.
Croatian: Prividni volumen distribucije (V/F) bio je 4,96 l pri tjelesnoj težini od 55 kg.
English: If MAS occurs, or is suspected, evaluation and treatment should be started as early as possible.
Croatian: Ako se pojavi MAS ili postoji sumnja na njega, što prije je potrebno započeti s evaluacijom i liječenjem.
English: No change in pharmacokinetic parameters based on clearance or volume of distribution were observed between elderly patients and adult patients < 65 years of age.
Croatian: Nisu bile uočene nikakve promjene u farmakokinetičkim parametrima na temelju klirensa ili volumena distribucije između starijih bolesnika i odraslih bolesnika u dobi od <65 godina.
English: Corticosteroid dose tapering:
Croatian: Smanjivanje doze kortikosteroida:
English: Ilaris has minor influence on the ability to drive and use machines.
Croatian: Ilaris malo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: Your doctor may want to check your vaccination history and give you any vaccinations that you have missed before you start treatment with Ilaris.
Croatian: Liječnik će Vam možda htjeti provjeriti anamnezu cijepljenja i dati Vam cjepiva koja ste propustili prije nego što započnete liječenje Ilarisom.